Maximus vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats Maximus overall, scoring 7.7/10 vs 7.1/10. MEDVi is more affordable at $299/mo vs $300/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of Maximus and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

Maximus

#46 of 48

7.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Maximus	MEDVi
Our Score	7.1/10	7.7/10
Starting Price	$300/mo	$299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Men who want GLP-1 alongside testosterone or other men's health protocols	Users who want a low entry price with oral and injectable compounded options
Ranking	#46	#22

Pros & Cons Compared

Maximus

Pros

+Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
+GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
+Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
+Free expedited shipping on all medication orders

Cons

−Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
−Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
−Prices increase as dose escalates on bulk plans — unpredictable total cost over time

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Maximus with a score of 7.7/10 vs 7.1/10. If budget is your priority, MEDVi starts at $299/mo compared to Maximus's $300/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Maximus nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review